B. Riley Financial, Inc. Adamis Pharmaceuticals Corp Transaction History

B. Riley Financial, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 04, 2018	SELL	$2.55 - $4.85 $592,181 - $1.13 Million	-232,228 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$3.5 - $5.65 $812,798 - $1.31 Million	232,228	232,228 $1.02 Million

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of B. Riley Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on B. Riley Financial, Inc. with notifications on news.